Literature DB >> 21860411

Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1.

H Gaude1, N Aznar, A Delay, A Bres, K Buchet-Poyau, C Caillat, A Vigouroux, C Rogon, A Woods, J-M Vanacker, J Höhfeld, C Perret, P Meyer, M Billaud, C Forcet.   

Abstract

LKB1 is a tumor suppressor that is constitutionally mutated in a cancer-prone condition, called Peutz-Jeghers syndrome, as well as somatically inactivated in a sizeable fraction of lung and cervical neoplasms. The LKB1 gene encodes a serine/threonine kinase that associates with the pseudokinase STRAD (STE-20-related pseudokinase) and the scaffolding protein MO25, the formation of this heterotrimeric complex promotes allosteric activation of LKB1. We have previously reported that the molecular chaperone heat shock protein 90 (Hsp90) binds to and stabilizes LKB1. Combining pharmacological studies and RNA interference approaches, we now provide evidence that the co-chaperone Cdc37 participates to the regulation of LKB1 stability. It is known that the Hsp90-Cdc37 complex recognizes a surface within the N-terminal catalytic lobe of client protein kinases. In agreement with this finding, we found that the chaperones Hsp90 and Cdc37 interact with an LKB1 isoform that differs in the C-terminal region, but not with a novel LKB1 variant that lacks a portion of the kinase N-terminal lobe domain. Reconstitution of the two complexes LKB1-STRAD and LKB1-Hsp90-Cdc37 with recombinant proteins revealed that the former is catalytically active whereas the latter is inactive. Furthermore, consistent with a documented repressor function of Hsp90, LKB1 kinase activity was transiently stimulated upon dissociation of Hsp90. Finally, disruption of the LKB1-Hsp90 complex favors the recruitment of both Hsp/Hsc70 and the U-box dependent E3 ubiquitin ligase CHIP (carboxyl terminus of Hsc70-interacting protein) that triggers LKB1 degradation. Taken together, our results establish that the Hsp90-Cdc37 complex controls both the stability and activity of the LKB1 kinase. This study further shows that two chaperone complexes with antagonizing activities, Hsp90-Cdc37 and Hsp/Hsc70-CHIP, finely control the cellular level of LKB1 protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21860411     DOI: 10.1038/onc.2011.342

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress.

Authors:  Szu-Wei Lee; Chien-Feng Li; Guoxiang Jin; Zhen Cai; Fei Han; Chia-Hsin Chan; Wei-Lei Yang; Bin-Kui Li; Abdol Hossein Rezaeian; Hong-Yu Li; Hsuan-Ying Huang; Hui-Kuan Lin
Journal:  Mol Cell       Date:  2015-02-26       Impact factor: 17.970

2.  CHIP protects against cardiac pressure overload through regulation of AMPK.

Authors:  Jonathan C Schisler; Carrie E Rubel; Chunlian Zhang; Pamela Lockyer; Douglas M Cyr; Cam Patterson
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

Review 3.  Minireview: hey U(PS): metabolic and proteolytic homeostasis linked via AMPK and the ubiquitin proteasome system.

Authors:  Sarah M Ronnebaum; Cam Patterson; Jonathan C Schisler
Journal:  Mol Endocrinol       Date:  2014-08-06

4.  Cardioprotective actions of Notch1 against myocardial infarction via LKB1-dependent AMPK signaling pathway.

Authors:  Hui Yang; Wanqing Sun; Nanhu Quan; Lin Wang; Dongyang Chu; Courtney Cates; Quan Liu; Yang Zheng; Ji Li
Journal:  Biochem Pharmacol       Date:  2016-03-22       Impact factor: 5.858

Review 5.  Targeting the LKB1 tumor suppressor.

Authors:  Rui-Xun Zhao; Zhi-Xiang Xu
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

6.  The double edge of the HSP90-CDC37 chaperone machinery: opposing determinants of kinase stability and activity.

Authors:  Wanping Xu; Len Neckers
Journal:  Future Oncol       Date:  2012-08       Impact factor: 3.404

7.  Carboxyl terminus of HSC70-interacting protein (CHIP) down-regulates NF-κB-inducing kinase (NIK) and suppresses NIK-induced liver injury.

Authors:  Bijie Jiang; Hong Shen; Zheng Chen; Lei Yin; Linsen Zan; Liangyou Rui
Journal:  J Biol Chem       Date:  2015-03-19       Impact factor: 5.157

Review 8.  Controlling the master-upstream regulation of the tumor suppressor LKB1.

Authors:  Lars Kullmann; Michael P Krahn
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

9.  A genome-wide RNAi screen for enhancers of par mutants reveals new contributors to early embryonic polarity in Caenorhabditis elegans.

Authors:  Diane G Morton; Wendy A Hoose; Kenneth J Kemphues
Journal:  Genetics       Date:  2012-08-10       Impact factor: 4.562

10.  LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.

Authors:  Christopher G Peña; Yuji Nakada; Hatice D Saatcioglu; Gina M Aloisio; Ileana Cuevas; Song Zhang; David S Miller; Jayanthi S Lea; Kwok-Kin Wong; Ralph J DeBerardinis; Antonio L Amelio; Rolf A Brekken; Diego H Castrillon
Journal:  J Clin Invest       Date:  2015-09-28       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.